Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amifostine: potential for clinically useful cytoprotection

G T Budd1, V Lorenzi, R Ganapathi

  • 1Department of Hematology/Medical Oncology, Cleveland Clinic Foundation, OH 44195.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|November 1, 1994
PubMed
Summary

Selective protection of normal tissues, like with amifostine, offers a promising strategy to improve cancer therapy effectiveness and reduce toxicity. This cytoprotectant agent shows potential in clinical studies for mitigating side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tracking flowpaths in a complex karst system through tracer test and hydrogeochemical monitoring: Implications for groundwater protection (Gran Sasso, Italy).

Heliyon·2024
Same author

Staphylococcus aureus adlb gene is associated with high prevalence of intramammary infection in dairy herds of northern Italy: A cross-sectional study.

Journal of dairy science·2023
Same author

Key role of hydrogen peroxide in antimicrobial activity of spring, Honeydew maquis and chestnut grove Corsican honeys on Pseudomonas aeruginosa DNA.

Letters in applied microbiology·2018
Same author

Cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells.

Blood cancer journal·2016
Same author

Disease risk assessment by clinical immunology analyses in periparturient dairy cows.

Research in veterinary science·2015
Same author

MicroRNA expression profiling in metastatic cutaneous squamous cell carcinoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2015

Area of Science:

  • Oncology
  • Pharmacology
  • Radioprotection

Background:

  • Targeting malignant cells while sparing normal tissues in cancer therapy presents significant challenges, leading to toxicity or ineffectiveness.
  • Selective protection of normal tissues is an alternative strategy to enhance the therapeutic window in cytotoxic therapy.

Purpose of the Study:

  • To explore amifostine as a selective cytoprotectant agent for normal tissues in cancer treatment.
  • To review the mechanisms and clinical evidence supporting amifostine's protective role.

Main Methods:

  • Pre-clinical studies investigating differential tissue concentration and activation of amifostine.
  • Clinical trials assessing amifostine's efficacy in reducing chemotherapy-induced toxicities, particularly myelosuppression.

Related Experiment Videos

Main Results:

  • Amifostine demonstrated differential concentration in normal tissues, attributed to tissue-specific alkaline phosphatase activity and pH.
  • Clinical studies indicated amifostine reduced myelosuppression associated with cyclophosphamide, cisplatin, and carboplatin regimens.

Conclusions:

  • Amifostine shows potential as a clinically useful cytoprotectant, enhancing the effectiveness of cytotoxic cancer therapies.
  • Further research is needed to define amifostine's role, including its integration with supportive care strategies.